| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | R43TR004228 | Multi-Tissue MAFLD Chip for Mechanism-Based Drug Testing | 000 | 1 | NIH | 11/1/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $966,068 ) |
| | 2024 | 2024 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | R44TR004524 | Hepatic Clearance Chip for Pharmacokinetics | 000 | 2 | NIH | 7/26/2024 | $974,458 |
| | 2024 | 2021 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | R43GM143980 | DDI-on-a-chip: an optimized liver microphysiological system and microenvironment for complex drug-drug interaction studies | 000 | 1 | NIH | 1/9/2024 | -$5,479 |
| | 2024 | 2019 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 000 | 2 | NIH | 8/2/2024 | $0 |
| | 2024 | 2019 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 001 | 2 | NIH | 9/9/2024 | -$2,911 |
|
| Issue Date FY: 2023 ( Subtotal = $919,990 ) |
| | 2023 | 2023 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | R44TR004524 | Hepatic Clearance Chip for Pharmacokinetics | 000 | 1 | NIH | 8/30/2023 | $1,009,594 |
| | 2023 | 2019 | JAVELIN BIOTECH INC | 299 WASHINGTON ST | WOBURN | MA | 01801-2793 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 000 | 2 | NIH | 5/15/2023 | -$89,604 |
|
| Issue Date FY: 2022 ( Subtotal = $314,803 ) |
| | 2022 | 2022 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | R43TR004228 | Multi-Tissue MAFLD Chip for Mechanism-Based Drug Testing | 000 | 1 | NIH | 8/18/2022 | $314,803 |
| | 2022 | 2021 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | R43GM143980 | DDI-on-a-chip: an optimized liver microphysiological system and microenvironment for complex drug-drug interaction studies | 000 | 1 | NIH | 4/7/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $259,613 ) |
| | 2021 | 2021 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | R43GM143980 | DDI-on-a-chip: an optimized liver microphysiological system and microenvironment for complex drug-drug interaction studies | 000 | 1 | NIH | 9/21/2021 | $259,613 |
| | 2021 | 2019 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 000 | 2 | NIH | 5/5/2021 | $0 |
| | 2021 | 2019 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 001 | 2 | NIH | 7/8/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,519,257 ) |
| | 2020 | 2019 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 002 | 2 | NIH | 9/25/2020 | $0 |
| | 2020 | 2019 | JAVELIN BIOTECH, INC. | 299 WASHINGTON ST | WOBURN | MA | 01801-2795 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 001 | 2 | NIH | 3/9/2020 | $1,519,257 |
|
| Issue Date FY: 2019 ( Subtotal = $1,435,688 ) |
| | 2019 | 2019 | JAVELIN BIOTECH, INC. | 206 CHARLES ST | CAMBRIDGE | MA | 02141-2004 | MIDDLESEX | USA | U24TR002634 | Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies | 001 | 2 | NIH | 8/5/2019 | $1,435,688 |
|
|
